Work

A Phase II Study of Azacitidine (Vidaza™) for Patients with Myelofibrosis (MF).

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2706.2706

Authors: Alfonso Quintas-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, Deborah Thomas, STeven Kornblau, Elihu Estey, Marilyn Nemri, Jorge Cortes, Francis Giles, Srdan Verstovsek

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2539951857

FWCI: 0.154

Cites:

Cited by: 1

Related to: 10